Some of these miRNAs were previously described to target genes associated with inflammation (cytokine-mediated pathways), fibrosis, and cancer development like USP28, WNT1, PHLDB2, BAX, MAP3K4, MET, RAB12, and ROCK1, among others. The gene discussed is MAP3K4; the disease is cancer.